MIRA Pharmaceuticals (NASDAQ: MIRA) shares soared 50.8% to $1.87 in after-hours trading on Wednesday after announcing promising results for their non-opioid pain drug, Mira-55, and plans for future ...

The Trump administration is cracking down on the flood of illicit flavored e-cigarettes that bad actors are illegally ...

Philip Morris International’s U.S. businesses ("PMI U.S.") unveiled "Invested in America," a bold advertising campaign that ...

Credera, Omnicom’s AI and technology unit, will help develop a launch playbook for Achieve Life Sciences’ cytisinicline.

"The medication's going to be 50 percent of your journey, and the other 50 percent is still what you choose to eat and the ...